{"entity":{"type":"insider","cik":"0001537250","url":"/insider/0001537250","json_url":"/insider/0001537250.json","name":"Harris Robert Paul","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":7,"n_filings":3,"first":"2013-03-20","last":"2016-11-30","span_basis":"filed_date"},"name_variants":[{"name":"Harris Robert Paul","source":"filing","n_filings":3,"first_seen":"2013-03-20","last_seen":"2016-11-30"}],"transactions":[{"id":2456291,"accession":"0001104659-16-159835","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-16-159835","line_url":"/filing/0001104659-16-159835#line-4","is_derivative":false,"issuer_cik":"0001537250","issuer_name":"Aralez Pharmaceuticals Inc.","issuer_ticker":"ARLZ","issuer_name_source":null,"issuer_url":"/issuer/0001537250","owner_cik":"0001537250","owner_name":"Harris Robert Paul","owner_display_name":"Harris Robert Paul","owner_url":"/insider/0001537250","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares, without par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":104778.0,"shares_display":"104,778","price_per_share":4.9929,"price_display":"4.99","price_state":"stated","total_value":523146.0762,"total_display":"523,146.08","total_whole":"523,146","shares_owned_after":594094.0,"shares_owned_after_display":"594,094","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-29","filed_date":"2016-11-30","scope":"insider"},{"id":2456282,"accession":"0001104659-16-159835","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-16-159835","line_url":"/filing/0001104659-16-159835#line-2","is_derivative":false,"issuer_cik":"0001537250","issuer_name":"Aralez Pharmaceuticals Inc.","issuer_ticker":"ARLZ","issuer_name_source":null,"issuer_url":"/issuer/0001537250","owner_cik":"0001537250","owner_name":"Harris Robert Paul","owner_display_name":"Harris Robert Paul","owner_url":"/insider/0001537250","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares, without par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":4.65,"price_display":"4.65","price_state":"stated","total_value":93000.0,"total_display":"93,000.00","total_whole":"93,000","shares_owned_after":594094.0,"shares_owned_after_display":"594,094","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-28","filed_date":"2016-11-30","scope":"insider"},{"id":2506167,"accession":"0001104659-16-145549","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-16-145549","line_url":"/filing/0001104659-16-145549","is_derivative":false,"issuer_cik":"0001537250","issuer_name":"Aralez Pharmaceuticals Inc.","issuer_ticker":"ARLZ","issuer_name_source":null,"issuer_url":"/issuer/0001537250","owner_cik":"0001537250","owner_name":"Harris Robert Paul","owner_display_name":"Harris Robert Paul","owner_url":"/insider/0001537250","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares, without par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":150000.0,"shares_display":"150,000","price_per_share":5.82145,"price_display":"5.82","price_state":"stated","total_value":873217.5,"total_display":"873,217.50","total_whole":"873,218","shares_owned_after":594094.0,"shares_owned_after_display":"594,094","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-09-15","filed_date":"2016-09-19","scope":"insider","n_lines":2},{"id":4317214,"accession":"0001537250-13-000002","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001537250-13-000002","line_url":"/filing/0001537250-13-000002#line-3","is_derivative":false,"issuer_cik":"0001159019","issuer_name":"Tribute Pharmaceuticals Canada Inc.","issuer_ticker":"TBUFF","issuer_name_source":null,"issuer_url":"/issuer/0001159019","owner_cik":"0001537250","owner_name":"Harris Robert Paul","owner_display_name":"Harris Robert Paul","owner_url":"/insider/0001537250","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":625000.0,"shares_display":"625,000","price_per_share":0.4,"price_display":"0.40","price_state":"stated","total_value":250000.0,"total_display":"250,000.00","total_whole":"250,000","shares_owned_after":8875000.0,"shares_owned_after_display":"8,875,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-02-27","filed_date":"2013-03-20","scope":"insider"},{"id":4317205,"accession":"0001537250-13-000002","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001537250-13-000002","line_url":"/filing/0001537250-13-000002","is_derivative":false,"issuer_cik":"0001159019","issuer_name":"Tribute Pharmaceuticals Canada Inc.","issuer_ticker":"TBUFF","issuer_name_source":null,"issuer_url":"/issuer/0001159019","owner_cik":"0001537250","owner_name":"Harris Robert Paul","owner_display_name":"Harris Robert Paul","owner_url":"/insider/0001537250","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1100000.0,"shares_display":"1,100,000","price_per_share":0.56,"price_display":"0.56","price_state":"stated","total_value":616000.0,"total_display":"616,000.00","total_whole":"616,000","shares_owned_after":8250000.0,"shares_owned_after_display":"8,250,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-03-22","filed_date":"2013-03-20","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":7,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":3,"open_market":true},{"code":"S","label":"Open-market sale","n":4,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":7},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001660719","name":"Aralez Pharmaceuticals Inc.","url":"/issuer/0001660719","role":"Director","n_filings":2,"first_seen":"2016-09-19","last_seen":"2016-11-30"},{"type":"issuer","type_label":"ISSUER","cik":"0001159019","name":"Tribute Pharmaceuticals Canada Inc.","url":"/issuer/0001159019","role":"Director, Officer (Chief Executive Officer)","n_filings":1,"first_seen":"2013-03-20","last_seen":"2013-03-20"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001537250","retrieved_at":"2026-08-24T04:57:04+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}